DR. SCHAUFLER
ACCESS ADVISORY
Building clarity at the intersection of strategy, evidence, and leadership.
I founded Dr. Schaufler Access Advisory to help Market Access leaders and their organizations navigate complex environments with confidence. During my years leading global teams, I often wished for a true sparring partner — someone who could bring an outside perspective, challenge constructively, and help turn good ideas into great strategies.
As a Strategic Catalyst, I work alongside clients to sharpen strategic thinking, strengthen evidence narratives, and build the executive presence required to make impact visible — both internally and externally.
After nearly two decades in the biopharmaceutical industry, I’ve learned that great strategies don’t just depend on smart thinking — they also need to be heard. That requires both evidence and leadership presence. My work bridges those dimensions, helping strategies stand up — to payers, policymakers, and management alike.
Every engagement starts with clarity — aligning insights, narratives, and leadership impact. I combine analytical depth with strategic empathy, helping clients see complexity clearly and act decisively. No layers, no templates — just peer-to-peer collaboration focused on co-creating outcomes that stand up.
Independent Consultant (since 2025)
Founder of Dr. Schaufler Access Advisory, supporting Market Access leaders on access, evidence, and policy strategy and strengthening their executive presence to get the recognition for the impact they deliver.
CSL Vifor (7 years)
Up to Global Head Health Economics and Outcomes Research.
Led global HEOR and launch strategies across nephrology and rare disease portfolios, including early access and evidence generation initiatives.
F. Hoffmann-La Roche (3 years)
Senior International Health Policy Leader, Global Access.
Developed cross-regional policy initiatives, Market Access strategies, and capability-building programs across emerging and established markets.
AbbVie (4 years)
Up to Global Market Access Lead.
Directed payer value strategy development and local reimbursement submissions; established special access pathways for innovative therapies.
Amgen (3 years)
Health Economics Manager.
Worked with clinical and academic partners to integrate real-world evidence into access planning and led local reimbursement submissions.
Pfizer (2 years)
Junior Manager Public Affairs.
Designed and executed policy initiatives and stakeholder events linking public health priorities with pharmaceutical innovation.